In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Brought to you by

Warner Chilcott completes $1bn IPO

27 Sep 2006

Executive Summary

Warner Chilcott (hormone therapeutics for women's health and dermatology conditions) has completed its IPO, netting just over $1bn with the sale of 70.6mm common shares at $15 each. The offering price was slightly under the asking price of between $17-19. The company will trade on Nasdaq again, just under two years after being bought out by Bain Capital, DLJ Merchant Banking, JP Morgan, and Thomas H. Lee Partners for $2.9bn.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

UsernamePublicRestriction

Register

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By